Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Sell
3,200
-13,711
-81% -$2.48M 0.34% 44
2026
Q1
$2.49M Buy
16,911
+2,730
+19% +$444K 1.58% 21
2025
Q4
$2.76M Buy
14,181
+3,812
+37% +$908K 1.7% 19
2025
Q3
$2.92M Sell
10,369
-2,132
-17% -$543K 1.87% 17
2025
Q2
$2.73M Buy
12,501
+1,501
+14% +$242K 1.94% 18
2025
Q1
$1.54M Buy
+11,000
New +$1.79M 1.06% 33

Other funds holding ORCL

Syntax Research's ORCL Position: Q2 2026 in Review

Syntax Research reduced its Oracle (ORCL) stake by 81% in Q2 2026, selling an estimated $2.48M and leaving 3,200 shares worth $469K. The position accounts for 0.34% of the portfolio, ranked #44.

Syntax Research first reported a position in ORCL in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.92M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Syntax Research held 3,200 shares of Oracle worth $469K as of Q2 2026.
  • Syntax Research sold 13,711 Oracle shares in Q2 2026, an estimated $2.48M.
  • Oracle made up 0.34% of Syntax Research's portfolio in Q2 2026, its #44 holding.
  • Syntax Research first reported a position in Oracle in Q1 2025 and has held it in 6 quarters since.
  • Syntax Research's Oracle position peaked at $2.92M in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.